Tesamorelin Reconstitution Chart (Every Vial Size)

Standard Tesamorelin Reconstitution Matrix

In analytical and preclinical laboratory settings, accurate solvent addition is critical for achieving target working concentrations. Tesamorelin is supplied as a lyophilized white powder that requires reconstitution with an appropriate solvent—typically bacteriostatic water (0.9% benzyl alcohol) or sterile water for injection—prior to in vitro assaying or animal model administration.

The following reference matrix outlines the resulting concentration (mg/mL) and microgram payload per 0.1 mL volumetric aliquot across standard mass-to-volume combinations. Researchers can cross-reference these values or utilize our interactive reconstitution calculator for custom assay parameters.

| Vial Mass (mg) | Diluent Volume (mL) | Resulting Concentration (mg/mL) | Payload per 0.1 mL Volumetric Aliquot (mcg) | |---|---|---|---| | 2 mg | 1.0 mL | 2.0 mg/mL | 200 mcg | | 2 mg | 2.0 mL | 1.0 mg/mL | 100 mcg | | 5 mg | 1.0 mL | 5.0 mg/mL | 500 mcg | | 5 mg | 2.5 mL | 2.0 mg/mL | 200 mcg | | 5 mg | 5.0 mL | 1.0 mg/mL | 100 mcg | | 10 mg | 2.0 mL | 5.0 mg/mL | 500 mcg | | 10 mg | 4.0 mL | 2.5 mg/mL | 250 mcg | | 10 mg | 5.0 mL | 2.0 mg/mL | 200 mcg |

When referencing our catalog of all peptides, investigators should select vial configurations that minimize repeated freeze-thaw cycles while maintaining concentration precision suitable for their laboratory instrumentation.

Mathematical Formula for Laboratory Reconstitution Calculations

Calculating peptide concentration post-reconstitution relies on volumetric concentration equilibrium. The fundamental equation governing mass concentration ($C$) in a liquid phase is expressed as the total lyophilized peptide mass ($M$) divided by the total diluent volume ($V$).

Formulas for volumetric working assays: 1. Target Concentration ($C$ in mg/mL) = $\frac{\text{Peptide Mass } (M \text{ in mg})}{\text{Diluent Volume } (V \text{ in mL})}$ 2. Single Aliquot Payload ($P$ in mcg per $V_a$ mL) = $C (\text{in mg/mL}) \times 1000 \times V_a (\text{in mL})$ Where $M$ is the certified net peptide mass declared on the lot-specific analytical documentation, $V$ is the added volume of bacteriostatic or sterile diluent, and $V_a$ represents the pipetted sample volume (typically 0.1 mL in volumetric measurements).

Researchers conducting high-throughput screening must account for vial displacement volume. While the displacement volume of lyophilized peptide cakes under 10 mg is statistically negligible in macro-volume reconstitutions (>1.0 mL), precision micro-pipetting protocols requiring high molar concentration accuracy should factor in displacement parameters.

Worked Calculations for Research Protocols

To illustrate the practical application of these mathematical principles in laboratory environments, consider the following two worked research scenarios.

Worked Example A: Reconstituting a 10 mg Vial for Standard In Vitro Assays An investigator opens a lyophilized vial containing tesamorelin 10mg and intends to yield a working stock concentration of 2.5 mg/mL. Applying Formula 1: $V = \frac{M}{C} = \frac{10 \text{ mg}}{2.5 \text{ mg/mL}} = 4.0 \text{ mL}$ Adding 4.0 mL of bacteriostatic water into the 10 mg vial yields a final concentration of 2.5 mg/mL. Each 0.1 mL volumetric draw delivers: $P = 2.5 \text{ mg/mL} \times 1000 \times 0.1 \text{ mL} = 250 \text{ mcg}$.

Worked Example B: Reconstituting a 5 mg Vial for Low-Volume Micro-Dosing Assays A laboratory requires a 1.0 mg/mL stock solution from a 5 mg lyophilized vial. Applying Formula 1: $V = \frac{5 \text{ mg}}{1.0 \text{ mg/mL}} = 5.0 \text{ mL}$ Adding 5.0 mL of bacteriostatic water to the 5 mg vial establishes a final concentration of 1.0 mg/mL. Under this setup, a 0.1 mL pipetted volume yields 100 mcg of active compound.

Reconstitution Mechanics and Solvent Selection

Selecting the correct reconstitution solvent depends on the planned experimental duration and protocol requirements. Bacteriostatic water preserved with 0.9% benzyl alcohol is the standard diluent for multi-use research vials, as the bacteriostatic agent inhibits microbial growth during storage at 2°C to 8°C for up to 28 days.

For acute in vitro cellular assays sensitive to benzyl alcohol toxicity, sterile 0.9% sodium chloride (normal saline) or sterile water for injection (SWFI) is preferred. However, solutions reconstituted with non-preserved diluents must be used immediately or partitioned into single-use aliquots and frozen at -20°C to maintain biological integrity and prevent microbial contamination.

During solvent introduction, direct the liquid stream down the glass interior wall of the vial rather than shooting directly onto the lyophilized cake. Allow the diluent to gently saturate the cake, then roll the vial slowly between your palms. Rapid agitation, vigorous shaking, or vortexing must be strictly avoided, as shear forces can induce peptide denaturation, aggregation, or precipitation.

Biochemical Profile and Structure of Tesamorelin

Tesamorelin is a synthetic 44-amino-acid peptide analog of human growth hormone-releasing hormone (GHRH). It features a hexenoyl group attached to the N-terminal residue (trans-3-hexenoic acid modification), which enhances enzymatic stability against dipeptidyl peptidase-IV (DPP-IV) cleavage compared to endogenous GHRH(1-44) amide.

Preclinical studies suggest that this structural modification extends the systemic half-life of the compound while preserving selective binding affinity for the GHRH receptor (GHRHR) located on anterior pituitary somatotrophs. Binding stimulates the cyclic adenosine monophosphate (cAMP) signal transduction pathway, driving endogenous growth hormone (GH) synthesis and downstream insulin-like growth factor 1 (IGF-1) expression.

Because of its high receptor selectivity, tesamorelin serves as an essential research tool in preclinical models investigating the somatotrophic axis, central endocrine signaling, metabolic regulation, and hepatic lipid oxidation.

Comparative GHRH Analog Analysis in Research Contexts

When evaluating candidates for neuroendocrine or metabolic studies, researchers frequently compare tesamorelin against other synthetic peptides that target the GH/IGF-1 axis.

In experimental models, tesamorelin exhibits distinct binding kinetics and half-life characteristics compared to truncated GHRH analogs such as sermorelin or non-selective secretagogues like cjc-1295. While sermorelin consists of the core 29-amino-acid catalytic sequence of natural GHRH, tesamorelin retains the extended 44-amino-acid structure reinforced by trans-3-hexenoic acid, providing greater metabolic stability in plasma incubation models. Additionally, ghrelin receptor agonists like ipamorelin operate through distinct growth hormone secretagogue receptors (GHS-R1a), making combined GHRH/GHS-R cross-activation protocols a frequent subject of dual-receptor in vitro studies.

To explore technical specifications across these class analogs, consult our comprehensive research library or review our wholesale account options for high-throughput structural comparative studies.

Preclinical Research Focus: Metabolic and Tissue-Repair Pathways

Preclinical literature demonstrates that tesamorelin is primarily studied as a growth-hormone-releasing hormone analog for elevating GH/IGF-1 signaling, supporting metabolic regulation, and exploring tissue-repair research.

In rodent models of visceral adiposity and hepatic steatosis, administration of GHRH analogs has been shown to modulate lipid metabolism by promoting lipolysis and reducing triglyceride accumulation in hepatocytes. In vitro data indicate that elevated GH signaling upregulation enhances basal metabolic rate pathways and transcription factors involved in fatty acid beta-oxidation.

Furthermore, tissue-repair research protocols utilize tesamorelin to examine peripheral nerve regeneration, collagen matrix synthesis, and muscle protein turnover. The compound's downstream modulation of circulating IGF-1 provides a controlled pathway for evaluating cellular proliferation and extracellular matrix remodeling in injured tissue models.

Laboratory Handling, Solubility, and Thermal Stability

Lyophilized tesamorelin exhibits high stability when stored in desiccated conditions at -20°C prior to reconstitution. Exposure to ambient temperatures during short-term transit does not compromise structural integrity, but long-term storage demands thermal control to prevent moisture absorption and peptide degradation.

Post-reconstitution stability is highly dependent on temperature, pH, and solvent composition. Reconstituted solutions using bacteriostatic water maintain physicochemical stability at 2°C to 8°C for up to 28 days. Avoid repeated freeze-thaw cycles of reconstituted liquid solutions, as ice crystal formation damages tertiary peptide structures and leads to irreversible aggregate formation.

If aliquoting for sub-zero storage (-20°C or -80°C), utilize low-protein-binding polypropylene microcentrifuge tubes. This prevents hydrophobic adherence of the peptide to container walls, preserving precise concentration metrics for subsequent analytical assays.

Quality Control & Purity Verification Standards

Analytical precision in laboratory research requires high-purity research compounds backed by verifiable lot documentation. Impurities or truncated peptide fragments resulting from sub-standard synthesis can invalidate binding assays, introduce cytotoxic artifacts in cell cultures, or alter target receptor affinities.

PX1 Research enforces strict quality control standards for every production batch manufactured in the USA:

- **High-Performance Liquid Chromatography (HPLC):** Confirms chemical purity exceeding 99.0%, ensuring negligible presence of synthetic byproducts.

- **Mass Spectrometry (MS):** Verifies correct sequence mass-to-charge ratio and exact molecular mass confirmation.

- **Endotoxin Testing:** Ensures endotoxin levels remain below strict limits (<0.01 EU/mg) to prevent non-specific inflammatory responses in cellular assays.

- **ISO 17025 & GMP Compliance:** All analysis is conducted in ISO 17025 accredited testing facilities operating under current Good Manufacturing Practices.

Investigators can review independent, lot-specific certificates of analysis by visiting our dedicated COA lookup portal.